| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/17/2012 | CA2385456C 9-(piperazinylalkyl) carbazoles as bax-modulators |
| 01/17/2012 | CA2345208C Protective recombinant haemophilus influenzae high molecular weight proteins |
| 01/17/2012 | CA2264191C Recombinant toxin fragments |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006596A2 Anti-human respiratory syncytial virus (rsv) antibodies and methods of use |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006437A2 Polypeptides having antiviral activity and methods for use thereof |
| 01/12/2012 | WO2012006395A1 Respiratory syncytial virus antigenic compositions and methods |
| 01/12/2012 | WO2012006321A2 Novel antibacterial compounds, methods of making them, and uses thereof |
| 01/12/2012 | WO2012006315A2 Methods of immune modulation |
| 01/12/2012 | WO2012006180A1 Hiv immunogens |
| 01/12/2012 | WO2012006104A2 Compounds and methods for treating tuberculosis infection |
| 01/12/2012 | WO2012006070A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/12/2012 | WO2012006060A1 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/12/2012 | WO2012006055A2 Compounds and methods for the treatment or prevention of flavivirus infections |
| 01/12/2012 | WO2012005622A1 Composition for the prophylaxis of candidiasis |
| 01/12/2012 | WO2012005311A1 Composition for contact lens care |
| 01/12/2012 | WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 01/12/2012 | WO2012004875A1 Novel substance separated from orchidaceous plant, and extract, antioxidant, antibacterial agent, anticancer agent and antiinflammatory agent containing same |
| 01/12/2012 | WO2012004768A1 Propofol for use as an antiviral medicament |
| 01/12/2012 | WO2012004669A1 Polyethylene glycol compositions for controlling relapse of herpes labialis, herpes genitalis, and herpes zoster |
| 01/12/2012 | WO2012004212A1 Heterocyclic antiviral compounds |
| 01/12/2012 | WO2012003995A1 Lipid-conjugated antibodies |
| 01/12/2012 | WO2012003814A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |
| 01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
| 01/12/2012 | WO2012003704A1 Sodium alginate crosslinked slow-released moxiflorxacin microsphere, the preparation method and the use thereof, and target vascular occlusive agent of the microsphere |
| 01/12/2012 | WO2012003642A1 Fused tricyclic compounds and use thereof for treating viral diseases |
| 01/12/2012 | WO2012003554A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 01/12/2012 | WO2011113060A3 Antiviral compounds and methods of use thereof |
| 01/12/2012 | WO2011111971A3 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives |
| 01/12/2012 | WO2011106574A9 Inhibitors for antiviral use |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120010298 Method for synthesizing (E)-Anethol and Related Compounds By Cross Coupling Reaction of Potassium alllyltrifluroborate and 4-bromoanisole and aryl halides |
| 01/12/2012 | US20120010284 Controlled release of biologically active compounds from multi-armed oligomers |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010281 Antimicrobial and antitubercular compounds |
| 01/12/2012 | US20120010279 Composition comprising (-)-delta9-trans-tetrahydrocannabinol |
| 01/12/2012 | US20120010278 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections |
| 01/12/2012 | US20120010256 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 01/12/2012 | US20120010254 Compounds and methods for treatment of influenza |
| 01/12/2012 | US20120010246 Compositions and methods for treating diseases of the nail |
| 01/12/2012 | US20120010233 Methods and compositions to inhibit edema factor and adenylyl cyclase |
| 01/12/2012 | US20120010227 Formulation for nail and nail bed diseases |
| 01/12/2012 | US20120010222 Gyrase Inhibitors and Uses Thereof |
| 01/12/2012 | US20120010221 Tablet and granulated powder containing 6-fluoro-3-hydroxy-2-pyrazinecarboxamide |
| 01/12/2012 | US20120010215 Treatment of bacterial diseases of the respiratory organs |
| 01/12/2012 | US20120010213 Oral controlled release dosage forms for water soluble drugs |
| 01/12/2012 | US20120010200 Biaryl Heterocyclic Compounds And Methods Of Making And Using The Same |
| 01/12/2012 | US20120010197 Protein kinase inhibitors |
| 01/12/2012 | US20120010187 Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
| 01/12/2012 | US20120010181 Compounds for the treatment of inflammatory disorders |
| 01/12/2012 | US20120010180 Soluble dosage forms containing cephem derivatives suitable for parenteral administration |
| 01/12/2012 | US20120010173 Fosfluconazole Derivatives, Synthesis, and Use in Long Acting Formulations |
| 01/12/2012 | US20120010171 Nucleotide Analogue Prodrug and the Preparation Thereof |
| 01/12/2012 | US20120010170 "Methods of Reducing Nephrotoxicity in Subjects Administered Nucleoside Phosphonates" |
| 01/12/2012 | US20120010167 Countermeasure methods and devices |
| 01/12/2012 | US20120010164 Antiviral agents |
| 01/12/2012 | US20120010163 Novel antibacterial compounds, methods of making them, and uses thereof |
| 01/12/2012 | US20120010162 Method for treatment of lung infections by administration of aminoglycosides by aerolisation |
| 01/12/2012 | US20120010131 Novel cyclosporin analogues |
| 01/12/2012 | US20120010130 Composition for preventing virus infection comprising poly-gamma-glutamic acid |
| 01/12/2012 | US20120010127 Compositions Comprising Multiple Bioactive Agents, and Methods of Using the Same |
| 01/12/2012 | US20120010126 Recombinant surfactant protein d compositions and methods of use thereof |
| 01/12/2012 | US20120009290 Compositions for skin diseases or disorders |
| 01/12/2012 | US20120009289 Water-soluble antiviral product containing cyperus articulatus, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof |
| 01/12/2012 | US20120009286 Water-soluble antiviral product containing momordica balsamina, for the treatment and prevention of acquired immunodeficiency syndrome (aids) and the variants thereof |
| 01/12/2012 | US20120009262 Medical apparatus and method for producing same |
| 01/12/2012 | US20120009256 Treatment Including Prebiotic Composition for use with Probiotics |
| 01/12/2012 | US20120009254 Respiratory Syncytial Virus Antigenic Compositions and Methods |
| 01/12/2012 | US20120009253 Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds of the lower respiratory tract |
| 01/12/2012 | US20120009247 Phospholipid drug analogs |
| 01/12/2012 | US20120009243 Liposomes for drug delivery and methods for preparation thereof |
| 01/12/2012 | US20120009221 Transfection of blood cells with mrna for immune stimulation and gene therapy |
| 01/12/2012 | US20120009220 Low Antigen-dose Immunization for Maximizing T-helper Cell 1 (Th1) Immunity Against a Pathogen |
| 01/12/2012 | US20120009219 Bacillus anthracis protective antigen sequences |
| 01/12/2012 | US20120009218 Attenuated Gram Negative Bacteria |
| 01/12/2012 | US20120009216 Early detection of flaviviruses using the ns1 glycoprotein |
| 01/12/2012 | US20120009214 Intergenic regions as novel sites for insertion of hiv dna sequences in the genome of modified vaccinia virus ankara |
| 01/12/2012 | US20120009213 Meningococcal And Pneumococcal Conjugate Vaccine And Method Of Using Same |
| 01/12/2012 | US20120009212 Conjugates utilizing platform technology for stimulating immune response |
| 01/12/2012 | US20120009211 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 01/12/2012 | US20120009209 Enrichment and purification of infectious prion proteins |
| 01/12/2012 | US20120009206 Novel double-stranded ribonucleic acids with rugged physico-chemical structure and highly specific biologic activity |
| 01/12/2012 | US20120009202 Target host factors for treating viral infection |
| 01/12/2012 | US20120009196 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | US20120009188 Optimized fc variants |
| 01/12/2012 | US20120009182 Immunoglobulin variants with altered binding to protein a |
| 01/12/2012 | US20120009170 METHOD OF TREATING INFLAMMATORY LUNG DISEASE WITH SUPPRESSORS OF CpG OLIGONUCLEOTIDES |
| 01/12/2012 | US20120009169 Self-forming phospholipidic gels |
| 01/12/2012 | US20120009153 Compositions for bacterial mediated gene silencing and methods of using the same |
| 01/12/2012 | US20120009151 Triazines And Related Compounds Having Antiviral Activity, Compositions And Methods Thereof |
| 01/12/2012 | US20120009150 Diaryl ureas for treating virus infections |
| 01/12/2012 | US20120009148 Methods of predicting responsiveness to interferon treatment and treating hepatitis c infection |
| 01/12/2012 | US20120009147 2'-fluoro substituted carba-nucleoside analogs for antiviral treatment |
| 01/12/2012 | US20120009144 Heterocyclic antiviral compounds |
| 01/12/2012 | US20120009142 Methods for treating hepatitis c |
| 01/12/2012 | US20120009130 Viral Therapy and Prophylaxis Using Nanotechnology Delivery Techniques |
| 01/12/2012 | US20120006716 Humanized anti-il-6 antibodies |
| 01/12/2012 | US20120006715 Feminine fresh all day |